Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CAV2 |
| Upstream (Parents) |
|---|
| (<<) CAV1 → CAV2 |
| (<<) LPAR6 → CAV2 |
| Downstream (Children) |
|---|
| CAV2 → CPE (>>) |
| CAV2 → PRPF19 (>>) |
| CAV2 → CSRP2 (>>) |
| CAV2 → HSD17B11 (>>) |
| CAV2 → ITGB1BP1 (>>) |
| CAV2 → THSD7A (>>) |
| CAV2 → GNAI1 (>>) |
| CAV2 → RARG (>>) |
| CAV2 → TRBV10-2 (>>) |
| CAV2 → PCNXL2 (>>) |
| CAV2 → TMEM100 (>>) |
| CAV2 → KHDRBS3 (>>) |
| CAV2 → PDE4C (>>) |
| CAV2 → GALNT12 (>>) |
| CAV2 → EMX2 (>>) |
| CAV2 → ACN9 (>>) |
| CAV2 → ATP11A (>>) |
| CAV2 → ASPA (>>) |
| CAV2 → SPRY2 (>>) |
| CAV2 → C10orf137 (>>) |
| CAV2 → INSL5 (>>) |
| CAV2 → HHLA2 (>>) |
